Publication Type:

Journal Article

Source:

Annals of Pediatric Cardiology, Volume 2, Number 1, p.74-78 (2009)

URL:

http://www.scopus.com/inward/record.url?eid=2-s2.0-77953448744&partnerID=40&md5=948f051a515bdb6958ce9c46c7f1a3b3

Keywords:

bioassay, brain natriuretic peptide, carvedilol, Clinical trial, cyclosporin, digoxin, dizziness, drug bioavailability, drug clearance, drug contraindication, drug dose titration, drug efficacy, drug half life, drug information, drug mechanism, drug monitoring, drug safety, drug tolerability, dyspnea, e-mail, edema, first pass effect, gastrointestinal reflux, headache, health survey, heart atrium flutter, heart failure, heart left ventricle ejection fraction, human, hypotension, maintenance drug dose, medical expert, meta analysis, muscle fatigue, note, outcome assessment, pediatric advanced life support, pediatric cardiology, practice guideline, rifampicin, syncope, systematic review, thorax pain, treatment duration, treatment outcome, vomiting

Notes:

cited By (since 1996)0

Cite this Research Publication

B. Vaidyanathan, “Is there a role for carvedilol in the management of pediatric heart failure A meta analysis and e-mail survey of expert opinion”, Annals of Pediatric Cardiology, vol. 2, pp. 74-78, 2009.